GlassScriptPhysician profile
Marni G Hillinger
NPI 1194040535
$502.17
in general payments reported to CMS, 2019-2025
13 companies · $81.29 in 2025
The $81.29 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $16.65 · 2021: $42.97 · 2022: $146 · 2023: $41.94 · 2024: $15.64 · 2025: $81.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $115.99 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $87.12 | 2019-2023 | Evkeeza |
| Boston Scientific Corporation | $54.42 | 2025 | Cds - Mct/Cem Monitoring, Watchman Flx |
| Amarin Pharma, INC. | $43.23 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $39.21 | 2022-2024 | Xarelto |
| Vertex Pharmaceuticals Incorporated | $26.87 | 2025 | |
| Amryt Pharma Holdings LTD | $26.07 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.97 | 2021 | |
| Irhythm Technologies, INC. | $19.17 | 2023 | Zio Xt Patch |
| Astrazeneca Pharmaceuticals LP | $19.00 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $16.84 | 2022 | |
| Allergan, INC. | $16.65 | 2020 | |
| Ascend Therapeutics US, LLC | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marni Hillinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.